AlbA expression and purification. Plasmid containing the albA gene was constructed by amplifying albA from B. subtilis 168 strain. The oligonucleotides alba-F (GGTCTCAGCGCCTTGTTTATAGAGCAGATGTTTCCATTTATT) and alba-R (GGTCTCATATCCTAAATAAGCTGGACCACGTCTTCTAATTG) were used to amplify albA. The 1.8 kb BsaI/BsaI fragment containing the gene was ligated into pASK17+ plasmid to produce the recombinant plasmid pASK-albA expressing AlbA fused with an N-terminal strep-Tag. The entire cloned gene was sequenced to ensure that no error was introduced. E. coli BL21 (DE3) star transformed with pASK-albA were used to inoculate fresh LB medium (9 L) supplemented with ampicillin (100 µg.mL -1 ) and bacterial growth proceeded at 37°C until the OD600 reached between 0.6-0.8. Protein expression was induced by adding 9 mL of anhydrotetracycline (0.2 mg.mL -1 ). After 24 hours at 18°C, the cells were collected by centrifugation at 5,000 x g for 20 minutes. The cells were suspended in 10 mL of buffer A (Tris 50 mM, KCl 300 mM, NaCl 0.5 mM, glycerol 10%, pH 8). The cells were disrupted by sonication on ice after addition of Triton X100 and 0.5% of 2-mercaptoethanol. The protein extract was centrifuged at 45,000 x g at 4°C for 1.5 hour. The solution obtained was loaded onto a streptactin high capacity column (IBA) previously equilibrated with buffer A. The column was washed with 5 column volumes of buffer A. Proteins were eluted with 9 mL of buffer A containing 1 mM of desthiobiotin and dithiothreitol (DTT, 3 mM). The purified protein, after concentration, was stored at -80°C and the purity was assayed on a 12% SDS PAGE.
Spectrophotometric measurement. UV-visible absorption spectra were recorded on a Beckman DU 640 spectrophotometer.
AlbA assay. Enzymatic assays were carried out in an anaerobic chamber (Bactron IV) with an atmosphere constituted of 5% H 2 , 10% CO 2 and 85% N 2 . AlbA was reconstituted by adding 3 mM of DTT at 12°C during 15 minutes. Then, Na 2 S and (NH 4 )2Fe(SO 4 ) 2 (12 equivalents) were added and the solution was incubated at 12°C overnight. The protein was then desalted to remove unbounded iron and sulfide and concentrated. The reaction mixture was composed of AlbA (20 µM), peptide substrate (1 mM), S-adenosyl-L-methionine (1 mM) and DTT (6 mM). Incubations were performed at 25°C under strict anaerobic conditions with a one-electron donor (i.e. sodium dithionite or flavodoxin/flavodoxin reductase/NADPH+).
HPLC analysis. Samples (3 µL) were diluted with 27 µL of trifluoroacetic acid solution (TFA 0.1%). HPLC analysis was carried out on an Agilent 1200 series Infinity chromatographic system with a reversed phase column (LiChroCART RP-18e 5 µm). The column was equilibrated with 100% solvent A (H 2 O, 0.1% TFA) and solvent B (80% CH 3 CN, 0.1% TFA) was applied with the following gradient: 0-1 min 0% B; 1-15 min, a linear gradient to 20% B; 15-50 min, a linear gradient to 60% B; 50-55 min, a linear gradient to 0% B at a flow rate of 1 mL.min -1 .
LC-MS/MS analysis. LC-MS analysis was performed on an NanoLC-Ultra system (Eksigent). Each reaction was diluted 100 times and 4 µL were loaded at 7.5 µL.min -1 on a cartridge (stationary phase: PepMap 100 C 18 , 5 µm; column: 300 µm i.d., 5 mm; Dionex) and desalted with 0.1% formic acid (FA). After 3 min, the cartridge was connected to the separating C 18 column (stationary phase: C 18 Bio-sphere, 3 µm; column: 75 µm i.d., 150 mm; Nanoseparations). Buffers were H 2 O, 0.1% FA (A) and CH 3 CN, 0.1% FA (B). The peptide separation was achieved with a linear gradient from 5 to 65% for 30 min of buffer B at 300 nL.min -1 . Eluted peptides were analyzed on-line with a QExactive mass spec-trometer (Thermo Electron) using a nanoelectrospray interface piloted by Xcalibur 2.1 version. Peptide ionization was performed with picotip ermitters (20 µm i.d.; New objective) in a liquid junction with an ionization potential of 1.4 KV. Peptides were detected by the Orbitrap mass analyser in full MS scan mode with a range of mass-to-charge ratio (m/z) between 400 to 1400, at a resolution potency of 70000. The doubly charged ions corresponding to cyclic and linear peptides were specifically selected for fragmentation (MS/MS) during the complete separation by the HCD fragmentation mode with a normalized collision energy of 20%, at a resolution of 17,500. The spectra were merged and analyzed manually in Qualbrowser software (Thermo Xcalibur version 2.2.44).
Model of AlbA iron-sulfur centers. Using the structure of anSME (PDB: 4k38) and i-Tasser program a model for AlbA from residues 117 to 446 was generated (estimated r.m.s.d is of 4.1±2.8 Å, i-Tasser source). Based on i-Tasser, the best identified structural analog is anSME (PDB: 4k36). The structure superposition was performed with Coot using the SSM program and all residues.
Figure S1
Figure S1 -Peptides used in this study: The leader peptide which is cleaved after subtilosin A cyclization is indicated by purple residues while the residues in red are those involved in thioether bonds.
MKKAVIVENKGCATCSIGAACLVDGPIPDFEIAGATGLFGLWG
Based on SboA sequence, peptides covering the entire sequence of mature SboA have been synthesized.
Ac-SIGAACLVDGPIPDFEIAGA-NH 2 SboA 27-6 :
Ac-ATGLFGLWGNKGCAT-NH 2 SboA 27-6 -F:
Ac-ATGLFGLWGNKGCAT-NH 2 SboA 27-6 -C: Ac-ATGLFGLWGNKGCAT-NH 2
All synthetic peptides had a N-terminal acetylation and a C-terminal amidation. In SboA 27-6 -F, the letter F in red indicates a per-deuterated residue while in SboA 27-6 -C, the letter C in red indicates a (,-D 2 ) cysteine residue.
The theoretical molecular weights of singly-and doubly-charged parent ions (including posttranslational modifications) of the peptides used in this study are: Precursor peptide (SboA)
SboA 27 
Figure S5
Figure S5 -LC-MS 2 analysis of SboA 27-6 (a) and the cyclic peptide produced (b) by AlbA. AlbA (20 µM) was incubated in the presence of SAM (1 mM) and SboA 27-6 (1 mM) under anaerobic conditions with sodium dithionite (2 mM) as one-electron donor. Relevant fragments of the b and y series are indicated (see Table S2 for complete assignment). Table S3 for complete assignment). Table S4 for complete assignment). 
Figure S10
Figure S10 -UV-visible spectrum of purified wild-type (WT) AlbA and cysteine mutants after anaerobic reconstitution. C344A, C362A, C403 and C433A indicate the spectrum corresponding to AlbA single mutants: C344A, C362A, C403A and C433A. The A3 mutant lacks the radical SAM motif (Cx3Cx2C) while the A4 mutant is mutated on the four cysteine residues C344A, C362A, C403A and C433A. 
